Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Urologic Neoplasms × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Kidney Neoplasms 1 Kidney Diseases 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1

Interventions

enfortumab vedotin 2 pembrolizumab 1 avelumab 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02603432 2024-03-27

JAVELIN Bladder 100

Pfizer

Phase 3 Completed

700 enrolled 35 charts 2 FDA

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡